Sanjiv Modi is an expert in the field of Hematology. He attended University of Illinois College of Medicine at Chicago. University of Illinois College of Medicine at Chicago is ranked 49 in research and 85 in primary care medicine He has 1 awards "Meaningful Use Stage 1 Certification". Sanjiv S. Modi is also a published MD. He has 3 paper published. The most recent paper is: An open-label, single-arm, phase 2 trial of the polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer. He accepts Medicare.
NPI NUMBER | 1396730909 | |
NPPES Provider LastName | MODI | |
NPPES Provider FirstName | SANJIV | |
NPPES Provider ZIPCode | 604356433 | |
NPPES Provider State | IL | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 739.0 | |
Distinct Opioid Count | 3.0 | |
Opioid Claim Count | 73.0 | |
Percent Opioid Claims | 9.88 |
National Provider Identifier [NPI] | 1396730909 |
Last Name Of The Provider | MODI |
First Name Of The Provider | SANJIV |
View All |
![]() |
Nafisa D. Burhani, MB
![]() |